News

Tamiflu was already scheduled to be reviewed after it was approved for use in children in March 2004, but the evaluation took on greater significance following the deaths

These early-stage studies found Multiferon to be significantly more active against the virus than recombinant alpha interferon, recombinant beta interferon or ribavirin. The studies were conducted by Birmingham,

Adivar, sold as Serevent in Europe, is a major source of revenue for Glaxo, and shares in the company fell almost 5% after the news. GlaxoSmithKline criticized the

“Data such as these expand our understanding of the role Reyataz may play in anti-HIV regimens,” said Dr Jose Gatell, of the Hospital Clinic Provincial, Barcelona, Spain, and

This data, presented at the 9th European AIDS Conference, established that none of the 19 patients who met criteria for resistance testing and had resistance testing results available

The study successfully achieved its primary objective with an 89.5% response rate at study day 8 in Alinia-treated patients compared to 82.4% for metronidazole-treated patients. 142 patients were

In the 10-day monotherapy trial, patients taking MK-0518 achieved a 98% reduction in HIV-RNA across all dosages tested, and at least half achieved HIV-RNA copies of 400 per

IGN311, a humanized monoclonal antibody targeting the Lewis Y antigen, is being developed by Aphton’s subsidiary, Igeneon AG, as a potential new therapy for the treatment of cancer.

The study is designed to evaluate the safety, pharmacokinetic profile and antitumor activity of escalating doses of SGN-33, and is expected to enroll up to 60 patients at